PMID- 23219906 OWN - NLM STAT- MEDLINE DCOM- 20130725 LR - 20130129 IS - 1873-7544 (Electronic) IS - 0306-4522 (Linking) VI - 231 DP - 2013 Feb 12 TI - Chronic treadmill running protects hippocampal neurons from hypobaric hypoxia-induced apoptosis in rats. PG - 216-24 LID - S0306-4522(12)01162-1 [pii] LID - 10.1016/j.neuroscience.2012.11.051 [doi] AB - This study was designed to examine the effects of chronic running exercise (Ex) on the hypobaric hypoxia-induced neuronal injury in the hippocampus. Male Wistar rats (9 weeks old) were caged in a hypoxic altitude chamber simulating the condition of 9,000 m high (0.303 atm) for 7h and the brains were examined at 0, 4, and 24h after treatment. Hypoxia challenge increased the levels of caspase 3 (mean +/- SEM, % of baseline control, 121.9 +/- 11.8, 152.3 +/- 15.3, 141.6 +/- 7.0 for 0, 4 and 24h, respectively, n=5) and induced apoptosis (cell number, 205.7 +/- 8.8, 342.3 +/- 33.4, 403.0 +/- 12.2 for 0, 4 and 24h vs. 7.7 +/- 1.4 baseline control, n=3) in the hippocampal CA1 pyramidal neurons. The expression levels (% of control for 0, 4 and 24h, respectively, n=5) of hypoxia inducible factor-1alpha (HIF-1alpha; 150.5 +/- 8.1, 176.7 +/- 11.1, 136.2 +/- 13.3), neuronal nitric oxide synthase (nNOS; 163.4 +/- 9.6, 194.5 +/- 13.6, 163.7 +/- 10.9) and inducible nitric oxide synthase (iNOS; 139.4 +/- 9.5, 169.2 +/- 13.3, 134.3 +/- 13.0) and the degrees of microglia (cell number, 255.3 +/- 48.2, 349.0 +/- 57.3, 433.7 +/- 42.4 vs. 57.7 +/- 13.0 baseline control, n=3) and astrocyte (150.0 +/- 9.7, 199.3 +/- 10.8, 154.2 +/- 4.7) activation were increased by the hypoxia treatment, indicating that the brain was under hypoxic, oxidative and inflammatory stresses. Furthermore, the protein levels of hippocampal brain-derived neurotrophic factor (BDNF; 76.0 +/- 2.5, 76.1 +/- 7.1, 69.3 +/- 1.7 for 0, 4 and 24h, respectively, mean % of control +/- SEM, n=5) were reduced by the hypoxia treatment. Four weeks of treadmill Ex before hypoxia treatment significantly reduced the hypoxia-induced apoptosis (p<0.001, n=3) in the hippocampal CA1 neurons. Ex decreased the hypoxia-induced elevations of HIF-1alpha (p<0.001, n=5), nNOS (p<0.001, n=5) and iNOS (p<0.001, n=5) levels and activation of microglia (p=0.005, n=3) and astrocyte (p<0.001, n=5) status; whereas the hypoxia-reduced BDNF protein levels (p=0.013, n=5) were restored. Taken together, our results show that chronic Ex protects hippocampal CA1 neurons against hypobaric hypoxia insult. Ex-enhanced bioenergetic adaptation and anti-oxidative capacity may prevent neurons from hypoxia-induced apoptosis. Furthermore, activation of the BDNF signaling pathway may be involved in the Ex-induced protection. CI - Copyright (c) 2012 IBRO. Published by Elsevier Ltd. All rights reserved. FAU - Lin, C AU - Lin C AD - Department of Physiology, China Medical University, Taichung, Taiwan. clin33@mail.cmu.edu.tw FAU - Wu, C-J AU - Wu CJ FAU - Wei, I-H AU - Wei IH FAU - Tsai, M-H AU - Tsai MH FAU - Chang, N-W AU - Chang NW FAU - Yang, T-T AU - Yang TT FAU - Kuo, Y-M AU - Kuo YM LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20121207 PL - United States TA - Neuroscience JT - Neuroscience JID - 7605074 RN - 0 (Brain-Derived Neurotrophic Factor) RN - 0 (Hypoxia-Inducible Factor 1, alpha Subunit) RN - EC 1.14.13.39 (Nitric Oxide Synthase Type I) RN - EC 1.14.13.39 (Nitric Oxide Synthase Type II) SB - IM MH - Animals MH - Apoptosis/*physiology MH - Astrocytes/metabolism MH - Brain-Derived Neurotrophic Factor/metabolism MH - Hippocampus/*metabolism MH - Hypoxia, Brain/*metabolism MH - Hypoxia-Inducible Factor 1, alpha Subunit/metabolism MH - Inflammation MH - Male MH - Microglia/metabolism MH - Neurons/*pathology MH - Nitric Oxide Synthase Type I/metabolism MH - Nitric Oxide Synthase Type II/metabolism MH - Physical Conditioning, Animal/*physiology MH - Rats MH - Rats, Wistar MH - Running EDAT- 2012/12/12 06:00 MHDA- 2013/07/26 06:00 CRDT- 2012/12/11 06:00 PHST- 2012/10/01 00:00 [received] PHST- 2012/11/20 00:00 [revised] PHST- 2012/11/28 00:00 [accepted] PHST- 2012/12/11 06:00 [entrez] PHST- 2012/12/12 06:00 [pubmed] PHST- 2013/07/26 06:00 [medline] AID - S0306-4522(12)01162-1 [pii] AID - 10.1016/j.neuroscience.2012.11.051 [doi] PST - ppublish SO - Neuroscience. 2013 Feb 12;231:216-24. doi: 10.1016/j.neuroscience.2012.11.051. Epub 2012 Dec 7.